MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement

SAN DIEGO, Nov. 28, 2018 -- (Healthcare Sales & Marketing Network) -- MabVax Therapeutics Holdings, Inc. (OTC Pink: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the t... Biopharmaceuticals, Oncology, Venture Capital MabVax Therapeutics, monoclonal antibody, pancreatic cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news